Fetal monitors made by Philips Healthcare, Avalon Models FM20, FM30, FM40, and FM50 and ultrasound transducer, may produce inaccurate readings, the FDA has announced. Medscape Medical News
No Comments »
Filed under: General Health News
The burgeoning research fields of nanoscience and nanotechnology are commonly thought to be highly multidisciplinary because they draw on many areas of science and technology to make important advances.
No Comments »
Filed under: Pharmacy News
Australian doctors must be more transparent about their relationships with the pharmaceutical industry, including disclosing details of remuneration received and potential conflicts of interest, according to an article published in the Medical Journal of Australia.
No Comments »
Filed under: Pharmacy News
A common weed called American mayapple may soon offer an alternative to an Asian cousin that’s been harvested almost to extinction because of its anti-cancer properties. The near-extinct Asian plant, Podophyllyum emodi, produces podophyllotoxin, a compound used in manufacturing etoposide, the active ingredient in a drug used for treating lung and testicular cancer. Podophyllyum emodi [...]
No Comments »
Filed under: Pharmacy News
Local Drug Production Doesn’t Increase Access, Undermines Quality The international community focuses on lowering drug prices as a means of improving access and “today its idea is local pharmaceutical production …
No Comments »
Filed under: Pharmacy News
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
No Comments »
Filed under: Pharmacy News
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant [...]
No Comments »
Filed under: Pharmacy News
Ipsen (Euronext:IPN), an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen’s first-in-class [...]
No Comments »
Filed under: Pharmacy News
ETBOND TECHNOLOGY defines Biotechnology approach to fight H1N1 Influenza A (Swine Flu)
No Comments »
Filed under: Pharmacy News
Ipsen, an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen’s first-in-class inhibitor [...]
No Comments »
Filed under: Pharmacy News
